Skip to main content
. 2020 Sep 25;15(9):e0238500. doi: 10.1371/journal.pone.0238500

Fig 6.

Fig 6

(A) Representative western blot showing the absence of p53 acetylation in HPV positive cervical cancer cases compare to non-neoplastic control at site K305. (B) Representative panel of IHC showing the presence of p53 acetylation in HPV positive cervical cancer at site K373. The positive results were observed in very few cases. (C) Representative panel of IHC showing the absence of p53 acetylation in HPV positive cervical cancer at site K382.